Our solutions for dementia prediction

Innovation

Prodromic distinguishes patients early,
based on their future trajectory

Designed for the complexity of dementia

Prodromic combines data from cognitive tests, health records, imaging, blood biomarkers, genetics, and emerging proteomic signals.
The result: a unified patient‑level predictive score that captures a person's disease trajectory in ways invisible to standard methods.

Validated in the real world

Our AI has been tested on 20,000+ patients across 11 global datasets, spanning diverse demographics, geographies, and clinical settings.
The result: robust, generalizable performance for real clinical and commercial environments.

Modular, flexible, and future‑proof

With a library of ready to use AI engines, our platform adapts to different workflows—from low‑cost screening to biomarker‑rich precision trials.
The result: powerful insights using data that are already collected today, with the ability to integrate new biomarkers tomorrow.

Responsible AI, built for trust

Prodromic's models are interpretable and transparent, enabling clear communication with clinicians, regulators, and patients.
The result: confidence in health decisions that matter most.

We have a library of ready to use AI engines trained on different combinations of features. Example data types include:

• Demographics

• Cognitive tests

• Structural MRI

• PET (𝛃-amyloid)

• Genetics (APOE4)

• Blood tests (e.g., Ptau217)

AI engines have been validated on both research study data and real-world data sets from different geographies (North America, Europe, Asia).

Our solutions are currently research tools are not to be used as medical devices.